Lamivudine Capsules

This product is a broad-spectrum antifungal drug that can highly selectively inhibit fungal squalene epoxidase, block the squalene epoxidation reaction during the formation of fungal cell membranes, and interfere with the early biosynthesis of fungal sterols, thereby inhibiting and killing fungi. (See the instructions inside the package for details)

The main ingredient of this product is lamivudine.

This product is a capsule, and the contents are white or off-white granules and powder.

It is indicated for the treatment of adult patients with chronic hepatitis B with elevated alanine aminotransferase [ALT], viral activity and replication, and compensated liver function.

Oral administration. Adults take 0.1g (one tablet) once a day. (See the instructions inside the package for details)

The various serious adverse events reported with the use of lamivudine are also described in the Warnings and Precautions (lactic acidosis and severe liver enlargement with steatosis, exacerbation of hepatitis B after treatment, pancreatitis, and the emergence of viral mutations associated with decreased drug sensitivity and reduced response to treatment). Clinical studies conducted in patients with chronic hepatitis B have shown that lamivudine is well tolerated by most patients. The incidence of most adverse events was similar in patients in the lamivudine and placebo groups (see the table below for details). The most common adverse events were malaise and fatigue, respiratory tract infection, headache, abdominal discomfort and pain, nausea, vomiting, and diarrhea. Some adverse events (incidence ≥5%) that occurred during treatment in 3 placebo-controlled clinical trials in adults (see the package insert for details)

1. It is contraindicated for those who are allergic to lamivudine or any other ingredients in the preparation. 2. It is used with caution in lactating women.

Precautions for children: There is no data on the use of lamivudine in children in China. (See the instructions inside the package for details) Precautions for pregnancy and lactation: Use with caution in lactating women. Precautions for the elderly: See the dosage and usage for adults. (See the instructions inside the package for details)

If used with other drugs at the same time, drug interactions may occur. Please consult your doctor or pharmacist for details. (See the instructions inside the package for details)

Light-proof and sealed.

0.1g

24 months

Beijing Foyou Pharma Co., Ltd.

• Founded in:

  1999-02-03

• Address:

  No. 8 Guangyuan East Street, Tongzhou Industrial Development Zone, Tongzhou District, Beijing

• Tax NO.:

  91110112700216160K

• Registered Funds:

  480 million yuan

• Website:

  Log in to view

• Email:

  Log in to view